https://www.selleckchem.com/sc....reening/kinase-inhib
12% and 96.61%. For patients ≥ 65 years who survived the STEMI, observed survival at 3 and 5 years was 85.52% (95%CI, 82.23%-88.24%) and 75.43% (95%CI, 70.26%-79.83%), respectively. Expected survival at 3 and 5 years was 86.48% and 76.56%, respectively. For survivors of the acute event, life expectancy is fairly similar to that of the general population of the same age, sex, and geographical region. For survivors of the acute event, life expectancy is fairly similar to that of the general population of the same age, se
Like
Comment
Share
